4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000040
CEO bought 75,000 shares at an average $0.02 ($1,211)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-18 | Purchase : show line 1 in the form | +2,000 | $0.01 | $27 | 24,356,097 | D |
| 2019-06-18 | Purchase : show line 2 in the form | +5,000 | $0.01 | $67 | 24,361,097 | D |
| 2019-06-18 | Purchase : show line 3 in the form | +10,000 | $0.01 | $133 | 24,371,097 | D |
| 2019-06-18 | Purchase : show line 4 in the form | +1,000 | $0.01 | $13 | 24,372,097 | D |
| 2019-06-21 | Purchase : show line 5 in the form | +20,000 | $0.02 | $382 | 24,392,097 | D |
| 2019-06-21 | Purchase : show line 6 in the form | +5,000 | $0.02 | $98 | 24,397,097 | D |
| 2019-06-26 | Purchase : show line 7 in the form | +30,000 | $0.02 | $462 | 24,427,097 | D |
| 2019-06-26 | Purchase : show line 8 in the form | +2,000 | $0.02 | $30 | 24,429,097 | D |
| Open-market purchases · 75,000 sh · avg $0.02 · $1,211 | ||||||
Loading xslF345X03/primary_doc.xml…